Osaic Holdings’s BioRestorative Therapies BRTX Stock Holding History

Osaic Holdings’s Portfolio BRTX Stock Details BRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$760	Hold	2,000	–	–	﹤0.01%	7566
2026 Q1	$540	Hold	2,000	–	–	﹤0.01%	7416
2025 Q4	$2.36K	Sell	2,000 -193	-9%	-$257	﹤0.01%	7040
2025 Q3	$3.96K	Hold	2,193	–	–	﹤0.01%	6876
2025 Q2	$3.64K	Hold	2,193	–	–	﹤0.01%	6716
2025 Q1	$3.9K	Hold	2,193	–	–	﹤0.01%	6296
2024 Q4	$3.13K	Hold	2,193	–	–	﹤0.01%	6428
2024 Q3	$3.81K	Buy	2,193 +2,000	+1,036%	+$3.29K	﹤0.01%	6331
2024 Q2	$391	Sell	193 -2,001	-91%	-$2.88K	﹤0.01%	7044
2024 Q1	$3.03K	Hold	2,194	–	–	﹤0.01%	6307
2023 Q4	$3.82K	Hold	2,194	–	–	﹤0.01%	6270
2023 Q3	$3.93K	Buy	2,194 +300	+16%	+$756	﹤0.01%	6374
2023 Q2	$8.35K	Buy	1,894 +200	+12%	+$957	﹤0.01%	6066
2023 Q1	$5.76K	Hold	1,694	–	–	﹤0.01%	6259
2022 Q4	$5K	Hold	1,694	–	–	﹤0.01%	6268
2022 Q3	$5K	Hold	1,694	–	–	﹤0.01%	6340
2022 Q2	$5K	Buy	+1,694	New	+$7.18K	﹤0.01%	6452
2022 Q1	–	Sell	-194	Closed	-$1K	–	7250
2021 Q4	$1K	Buy	+194	New	+$1.11K	﹤0.01%	7143

Other funds holding BRTX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KFGK

Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Osaic Holdings's BRTX Position: Q2 2026 in Review

Osaic Holdings held its BioRestorative Therapies (BRTX) position steady in Q2 2026 at 2,000 shares worth $760. The position accounts for ﹤0.01% of the portfolio, ranked #7566.

Osaic Holdings first reported a position in BRTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.35K in Q2 2023. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

Osaic Holdings held 2,000 shares of BioRestorative Therapies worth $760 as of Q2 2026.
Osaic Holdings left its BioRestorative Therapies share count unchanged in Q2 2026.
BioRestorative Therapies made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7566 holding.
Osaic Holdings first reported a position in BioRestorative Therapies in Q4 2021 and has held it in 18 quarters since.
Osaic Holdings's BioRestorative Therapies position peaked at $8.35K in Q2 2023.
21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.